An introduction to network analysis for studies of medication use

Mohsen Askar,Raphael Nozal CaƱadas,Kristian Svendsen
DOI: https://doi.org/10.48550/arXiv.2106.00413
2021-06-01
Abstract:Background: Network Analysis (NA) is a method that has been used in various disciplines such as Social sciences and Ecology for decades. So far, NA has not been used extensively in studies of medication use. Only a handful of papers have used NA in Drug Prescription Networks (DPN). We provide an introduction to NA terminology alongside a guide to creating and extracting results from the medication networks. Objective: To introduce the readers to NA as a tool to study medication use by demonstrating how to apply different NA measures on 3 generated medication networks. Methods: We used the Norwegian Prescription Database (NorPD) to create a network that describes the co-medication in elderly persons in Norway on January 1, 2013. We used the Norwegian Electronic Prescription Support System (FEST) to create another network of severe drug-drug interactions (DDIs). Lastly, we created a network combining the two networks to show the actual use of drugs with severe DDIs. We used these networks to elucidate how to apply and interpret different network measures in medication networks. Results: Interactive network graphs are made available online, Stata and R syntaxes are provided. Various useful network measures for medication networks were applied such as network topological features, modularity analysis and centrality measures. Edge lists data used to generate the networks are openly available for readers in an open data repository to explore and use. Conclusion: We believe that NA can be a useful tool in medication use studies. We have provided information and hopefully inspiration for other researchers to use NA in their own projects. While network analyses are useful for exploring and discovering structures in medication use studies, it also has limitations. It can be challenging to interpret and it is not suitable for hypothesis testing.
Applications
What problem does this paper attempt to address?
This paper attempts to study drug use by introducing the Network Analysis (NA) method, especially co - medication and severe drug - drug interactions (DDIs) in the elderly population. Specifically, the main objectives of the paper are: 1. **Introduce the basic concepts and terms of network analysis**: The paper first gives a brief introduction to network analysis, including the basic structure of the network, nodes, edges, and the application of network analysis in different disciplines, such as sociology, ecology, etc. 2. **Show how to construct and analyze the drug - use network**: The paper describes in detail how to use the data from the Norwegian Prescription Database (NorPD) and the Norwegian Electronic Prescription Support System (FEST) to construct three different drug - use networks: - **Co - medication network**: Based on the co - medication data of the Norwegian elderly population on January 1, 2013. - **Severe drug - drug interaction network**: Based on the data of severe DDIs recorded in the FEST database. - **Combined network**: Combine the above two networks to show the drug combinations with actual severe DDIs. 3. **Apply and interpret network analysis indicators**: The paper shows how to apply different network analysis indicators, such as topological features (density, assortativity), modularity analysis, centrality measures (degree centrality, betweenness centrality, closeness centrality, eigenvector centrality), etc., to understand and interpret the structure and characteristics of the drug - use network. 4. **Provide practical tools and resources**: The paper provides specific usage methods of software tools (such as Stata, R, Gephi) for creating and analyzing networks, and discloses network data and code so that other researchers can repeat and expand these studies. In conclusion, this paper aims to provide a new perspective and tool for studying drug - use patterns through the network analysis method, especially for understanding co - medication in the elderly population and the potential risk of drug - drug interactions.